Sector: University & Research Institutions

Terran Biosciences has emerged from obscurity to snap up slew of IP rights in the past two months

NortonLifeLock has pledged to appeal the jury verdict, which could balloon to $550 million with enhanced damages for wilful infringement

Following major US CRISPR decision, Michael Arciero, VP of IP at ERS Genomics, tells IAM that tricky patent landscapes are the new normal in biotech

President Biden and other leaders are coming under pressure to agree a suspension of IP rights, but a key point has been missed

20 April 2021

Top voices from industry and private practice reckon with the strengths and weaknesses of country’s IP environment

15 April 2021

Long-running constitutional challenge putting 40% of patents at-risk set to be resolved, but further delays are possible

13 April 2021

Hub-and-spokes life sciences companies are providing new opportunities for IP monetisation

08 April 2021

Sigma-Aldrich’s patent loss could be a sign of things to come for several ongoing opposition proceedings

01 April 2021

Semiconductor Energy Lab settles US case against BOE and promptly targets China Star Optoelectronics, another major panel maker

29 March 2021

25 March 2021

25 March 2021

25 March 2021

25 March 2021

Get unlimited access to all IAM content